Related Experiment Video
Updated: Feb 25, 2026
15:18
Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
Published on: July 30, 2009
18.7K
Summary
The Pediatric MATCH trial, the largest study of targeted cancer drugs for children, has begun. It will initially investigate seven drugs, with plans to expand the treatment options.
Area of Science:
- Pediatric Oncology
- Clinical Pharmacology
Background:
- Targeted therapies have revolutionized cancer treatment in adults.
- Limited data exists on the efficacy and safety of targeted agents in pediatric and adolescent cancer patients.
- The need for novel therapeutic strategies in pediatric cancers remains high.
Purpose of the Study:
- To evaluate the safety and efficacy of targeted anticancer agents in children and adolescents.
- To identify specific genetic alterations that predict response to targeted therapies in pediatric malignancies.
- To establish a large-scale platform for testing multiple targeted drugs in diverse pediatric cancer types.
Main Methods:
- Pediatric MATCH is a large, multi-center basket study.
- It enrolls pediatric and adolescent patients with refractory or relapsed cancers.
- Patients receive treatment with targeted agents based on the molecular profile of their tumor.
Main Results:
- Patient enrollment commenced in late July.
- The study will initially evaluate seven targeted drugs.
- Expansion to include at least two additional drugs is planned.
Conclusions:
- The Pediatric MATCH trial represents a significant advancement in pediatric cancer research.
- This study aims to broaden the application of precision medicine in pediatric oncology.
- Findings are expected to inform future treatment guidelines for young cancer patients.
More Related Videos
Related Concept Videos
01:16Clinical Trials
10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.9K
01:11Clinical Trials: Overview
5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
286
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
286
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
329
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
329
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
359
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
359
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
375
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
375